Advanced search
Publication Cover
Pediatric Hematology and Oncology Latest Articles
Submit an article Journal homepage
37
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Utilization of supportive care medications and opportunities for pre-emptive pharmacogenomic testing in pediatric and young adults with leukemia

Colleen M. Sakona Indiana University Health, Indianapolis, Indiana, USAView further author information
,
Carmina Salesb Purdue University College of Pharmacy, Purdue University, West Lafayette, Indiana, USAView further author information
,
Selsbiel Mertamic Division of Clinical Pharmacology, Indiana University School of Medicine (IUSM), Indianapolis, Indiana, USAView further author information
,
Andra Raibuletd College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana, USAView further author information
,
Rachael R. Schultee Department of Pediatrics, Division of Pediatric Hematology/Oncology/Stem Cell Transplant, IUSM, Indianapolis, Indiana, USAView further author information
,
James E. Slavenf Department of Biostatistics and Health Data Science, IUSM, Indianapolis, Indiana, USAView further author information
&
Emma M. Tillmanc Division of Clinical Pharmacology, Indiana University School of Medicine (IUSM), Indianapolis, Indiana, USACorrespondence[email protected]
View further author information
 show all
Received 31 Jan 2024, Accepted 10 Jun 2024, Published online: 21 Jun 2024

References

  • Namayandeh SM, Khazaei Z, Lari Najafi M, Goodarzi E, Moslem A. GLOBAL leukemia in children 0-14 statistics 2018, incidence and mortality and human development index (HDI): GLOBOCAN sources and methods. Asian Pac J Cancer Prev. 2020;21(5):1487–1494. doi:10.31557/APJCP.2020.21.5.1487.
  • Childhood Leukemia – Cancer Stat Facts. SEER. Accessed October 14, 2023. https://seer.cancer.gov/statfacts/html/childleuk.html.
  • Berman R, Davies A, Cooksley T, et al. Supportive care: an indispensable component of modern oncology. Clin Oncol (R Coll Radiol). 2020;32(11):781–788. doi:10.1016/j.clon.2020.07.020.
  • Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–350. doi:10.1038/nature15817.
  • Maagdenberg H, Vijverberg SJ, Bierings MB, et al. Pharmacogenomics in pediatric patients: towards personalized medicine. Paediatr Drugs. 2016;18(4):251–260. doi:10.1007/s40272-016-0176-2.
  • Hicks JK, Bishop JR, Sangkuhl K, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98(2):127–134. doi:10.1002/cpt.147.
  • Crews KR, Monte AA, Huddart R, et al. Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther. 2021;110(4):888–896. doi:10.1002/cpt.2149.
  • Hicks JK, Sangkuhl K, Swen JJ, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017;102(1):37–44. doi:10.1002/cpt.597.
  • Saito Y, Stamp LK, Caudle KE, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharmacol Ther. 2016;99(1):36–37. doi:10.1002/cpt.161.
  • Bell GC, Caudle KE, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Clin Pharmacol Ther. 2017;102(2):213–218. doi:10.1002/cpt.598.
  • Relling MV, Schwab M, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update. Clin Pharmacol Ther. 2019;105(5):1095–1105. doi:10.1002/cpt.1304.
  • Patel JN. Opportunities for pharmacogenomics-guided supportive care in cancer. Support Care Cancer. 2021;29(2):555–557. doi:10.1007/s00520-020-05892-1.
  • Tran TH, Hunger SP. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Semin Cancer Biol. 2022;84:144–152. doi:10.1016/j.semcancer.2020.10.013.
  • Alexander TB, Wang L, Inaba H, et al. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials. Cancer. 2017;123(19):3791–3798. doi:10.1002/cncr.30791.
  • Patel JN, Olver I, Ashbury F. Pharmacogenomics in cancer supportive care: key issues and future directions. Support Care Cancer. 2021;29(11):6187–6191. doi:10.1007/s00520-021-06451-y.
  • Hunger SP, Raetz EA. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood. 2020;136(16):1803–1812. doi:10.1182/blood.2019004043.
  • Rubnitz JE, Kaspers GJL. How I treat pediatric acute myeloid leukemia. Blood. 2021;138(12):1009–1018. doi:10.1182/blood.2021011694.
  • Podpeskar A, Crazzolara R, Kropshofer G, et al. Supportive methods for childhood acute lymphoblastic leukemia then and now: a compilation for clinical practice. Front Pediatr. 2022;10:980234. doi:10.3389/fped.2022.980234.
  • Halverson CM, Pratt VM, Skaar TC, Schwartz PH. Ending the pharmacogenomic gag rule: the imperative to report all results. Pharmacogenomics. 2021;22(4):191–193. doi:10.2217/pgs-2020-0172.
  • Friedman JM, Bombard Y, Carleton B, et al. Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child? Genet Med. 2024;26(2):101033. doi:10.1016/j.gim.2023.101033.
  • Suhrie K, Tillman EM. Pharmacogenetic informed care in early childhood: options for improving access and health equity. Pharmacogenomics. 2023;24(11):579–582. doi:10.2217/pgs-2023-0119.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.